All lobbying filings

BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS · Pharmaceutical company

Filing Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 15, 2026

Income

$80,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 4

Commerce, Dept of (DOC)
HOUSE OF REPRESENTATIVES
SENATE
U.S. Trade Representative (USTR)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Pharmacy

issues related to pharmaceutical manufacturing Tax and trade policy affecting the pharmaceutical industry

Trade (domestic/foreign)

Companys expansion of its domestic footprint.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.